Search the Newsreel

DHR Maintains Buy Rating -- Price Target Lowered to $236 by TD C

TD Cowen has maintained a Buy rating on Danaher (DHR) but lowered its price target from $240 to $236, citing adjustments based on current market dynamics. Despite the revised target, Danaher is considered undervalued by GuruFocus, trading 25.6% below its GF Value™, and holds …

Danaher Posts Mixed Q2 Results, Outlook for 2027 and Beyond Strengthened, RBC Says

Danaher's (DHR) Q2 results were mixed, with the lumpier part of its bioprocess consumables business PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already have …

Can Danaher (DHR) Climb 32.39% to Reach the Level Wall Street Analysts Expect?

Danaher (DHR) closed the last trading session at $179.01, gaining 0% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of …

Danaher Stock Fell 11% After Earnings. Here’s What Could Drive It in 2026

Danaher Q2 2026 Deep Dive: EPS Beats by 4.9%, Revenue Up 6%

Danaher (DHR) reported Q2 2026 adjusted EPS of $1.94, beating estimates by 6.0%, and revenue of $6.3 billion, up 5.5% year-over-year. Despite the beat, the stock fell 14.9% due to sequential deceleration in earnings and modest 3.0% core revenue growth, alongside persistent bioprocessing headwinds. …

Danaher Earnings: Market Underwhelmed by 2026 Guidance, Including Bioprocessing Delays

Danaher reported strong second-quarter results with 3% core revenue growth and 8% adjusted EPS growth, surpassing analyst consensus. Despite an increased EPS outlook, the market was reportedly underwhelmed due to reduced core revenue growth assumptions and anticipated bioprocessing customer delays expected to impact late …

Earnings call transcript: Danaher beats Q2 2026 estimates but shares sink

Danaher (DHR) reported stronger-than-expected Q2 2026 earnings and revenue, but its stock dropped significantly in premarket trading. The decline was attributed to investor concerns over adjusted guidance and shifts in bioprocessing revenue timing, despite underlying strong order trends and an aggressive share repurchase program. …

Don’t Quit on Danaher Stock After Horrific Earnings Reaction

To say Danaher Corp. had a downbeat reaction to earnings is an understatement. Danaher had its worst day in two decades on Tuesday after the life sciences and diagnostics company’s second-quarter earnings. Danaher expects core revenue (a metric that excludes things like currency and …

U.S. RESEARCH ROUNDUP-Danaher, GM, MSCI

This article provides a roundup of rating and price target revisions by Wall Street securities analysts for various U.S.-listed companies, including Danaher, GM, and MSCI. The report details whether target prices were raised or cut and if ratings changed for a comprehensive list of …

Nahar Industrial Enterprises Share Price Forecast to 2030

Nahar Poly Films Share Price Forecast: 3 Year Outlook to 2030

Danaher (DHR) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Tuesday, July 21, 2026 at 8 a.m. ET CALL PARTICIPANTS Vice President of Investor Relations - Rachel VatnsdalPresident and Chief Executive Officer - Rainer BlairExecutive Vice President and Chief Financial Officer - Matt Gugino TAKEAWAYS Revenue -- $6.3 …

Why Danaher (DHR) Shares Are Falling Today

Why Danaher (DHR) Shares Are Falling Today What Happened? Shares of diversified science and technology company Danaher (NYSE:DHR) fell 13.3% in the morning session after it reported underwhelming second-quarter results. The negative reaction appeared to stem from underlying concerns about the company's profitability. While …

Danaher forecasts 3%-4% 2026 core revenue growth and raises adjusted EPS to $8.45-$8.60 following Masimo close

Earnings Call Insights: Danaher (DHR) Q2 2026 MANAGEMENT VIEW * "We delivered a solid second quarter with better-than-expected revenue, earnings and cash flow" (President, CEO & Director Rainer Blair), adding, "Our Life Sciences businesses delivered their strongest quarter in several years" and "the earlier-than-expected …

Danaher Plummets After One Segment Comes In 'Surprisingly Soft'

Danaher stock plummeted Tuesday after reporting what one analyst called "surprisingly soft" bioprocessing sales. Continue Reading

Behind Danaher’s Worst Stock Selloff in Over 30 Years

Danaher posts better-than-expected earnings, but its core revenue forecast disappoints and send shares tumbling. Continue Reading

Danaher Q2 Earnings Call Highlights

Key Points Interested in Danaher Corporation? Here are five stocks we like better. Danaher beat Q2 expectations with sales of $6.3 billion, adjusted EPS of $1.94, and $1.3 billion in free cash flow. Core revenue rose 3% year over year, with management saying performance …

Compared to Estimates, Danaher (DHR) Q2 Earnings: A Look at Key Metrics

For the quarter ended June 2026, Danaher (DHR) reported revenue of $6.27 billion, up 5.5% over the same period last year. EPS came in at $1.94, compared to $1.80 in the year-ago quarter. The reported revenue represents a surprise of +2.88% over the Zacks …

Danaher Corporation 2026 Q2 - Results - Earnings Call Presentation (NYSE:DHR) 2026-07-21

Danaher Corporation has published its 2026 Q2 earnings call presentation. This article by SA Transcripts provides access to the slide deck presented by Danaher in conjunction with their earnings call. SA Transcripts is responsible for publishing thousands of quarterly earnings calls and is continually …

Danaher Posts Q2 Results, Joins Calix, Equifax And Other Big Stocks Moving Lower In Tuesday’s Pre-Market

Danaher Corp (NYSE: DHR) shares dropped by 10.1% in pre-market trading despite reporting better-than-expected Q2 adjusted EPS and sales. Other companies also saw significant declines in pre-market trading, including Calix Inc and Equifax Inc, following their Q2 results or financial announcements. The broad market, …

Danaher Corporation (DHR) Q2 2026 earnings beat estimates; revenue up 5.5%

Danaher Corporation (DHR) reported stronger-than-expected adjusted earnings for Q2 2026, reaching $1.94 per share, surpassing estimates of $1.84 per share. The company's revenue increased by 5.5% year-over-year to $6.27 billion, also beating top-line estimates. Core revenue grew by 3.0%, with Life Sciences businesses achieving …

Danaher (DHR) Q2 Earnings and Revenues Top Estimates

Danaher (DHR) came out with quarterly earnings of $1.94 per share, beating the Zacks Consensus Estimate of $1.84 per share. This compares to earnings of $1.8 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings …

Danaher shares tumble despite earnings beat

Investing.com -- Danaher Corporation (NYSE:DHR) reported second quarter results that exceeded analyst expectations, but shares fell 9% premarket. The company posted adjusted earnings per share of $1.94, beating the analyst consensus of $1.84 by $0.10. Revenue reached $6.3 billion, surpassing the $6.1 billion estimate …

Danaher Q2 earnings jump 60% YoY, raises full-year profit forecast on strong growth and Masimo deal.

Danaher Corporation announced a 60% year-over-year increase in Q2 2026 net earnings, reaching $870 million, primarily due to robust core growth and the swift acquisition of Masimo. Revenues climbed 5.5% to $6.3 billion, with adjusted earnings per share rising 8% to $1.94. The company …

Danaher (NYSE:DHR) Posts Better-Than-Expected Sales In Q2 CY2026 But Stock Drops

Danaher (NYSE:DHR) Posts Better-Than-Expected Sales In Q2 CY2026 But Stock Drops Diversified science and technology company Danaher (NYSE:DHR) reported Q2 CY2026 results exceeding the market's revenue expectations , with sales up 5.5% year on year to $6.27 billion. Its non-GAAP profit of $1.94 per …

Earnings Flash (DHR) Danaher Corporation Reports Q2 Revenue $6.27B, vs. FactSet Est of $6.11B

Danaher Corporation (DHR) reported its Q2 revenue at $6.27 billion, surpassing FactSet's estimate of $6.11 billion. This earnings flash was published by MT Newswires, indicating Danaher's stronger-than-expected financial performance for the second quarter. The company also raised its 2026 guidance and posted adjusted EPS …

Danaher: Q2 Earnings Snapshot

This article provides a brief earnings snapshot for Danaher's Q2 performance. Due to the limited content, specific financial details are not available.

Danaher reports Q2 2026: Revenue $6.27B, Net earnings $870M, Adj. diluted EPS $1.94

Danaher reported robust Q2 2026 financial results with revenue of $6.27 billion and net earnings of $870 million. The company's adjusted diluted EPS grew 8.0% year-over-year to $1.94, and it generated significant operating and free cash flow. Danaher also raised its full-year 2026 adjusted …

Danaher Reports Second Quarter 2026 Results

WASHINGTON, July 21, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) today announced results for the second quarter 2026. All results in this release reflect only continuing operations and period-to-period comparisons are year-over-year unless otherwise noted. Key Second Quarter 2026 Results Net earnings were $870 …

Las acciones de Danaher caen pese a superar las expectativas de resultados

Danaher-Aktie fällt nach Masimo-Schluss trotz angehobener Prognose: Wa

Danaher Q2 Earnings Beat Estimates, Life Sciences Sales Up Y/Y

Danaher Earnings Beat Estimates. Why the Stock Is Dropping Most Since 1991.

Danaher Corp (DHR) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and Raised EPS Guidance

Wentworth Funding LLC (BCG) discloses 5.3% Binah Capital stake via stock and warrants

Wentworth Funding LLC has disclosed a 5.3% beneficial ownership stake in Binah Capital Group, Inc. (BCG) through a Schedule 13G/A filing. The stake comprises 894,977 shares, including 233,818 shares underlying currently exercisable warrants with an exercise price of $11.50 per share. This ownership grants …

Danaher leads volatile earnings moves with $7.58 billion at stake

Danaher Corp. is set to lead significant earnings-related market volatility with a potential $7.58 billion market value swing, as options price a 5.30% move ahead of its Q2 2026 earnings report. Interactive Brokers Group shows the highest implied volatility on the watchlist at 6.20%, …